xCures Announces Collaboration with CancerCompass
Today, xCures announced their collaboration with CancerCompass, allowing consumers who contact CancerCompass to access the xCures' platform and services.Consumers who [...]
Komodo Health Acquires Mavens
Today, Komodo Health announced the acquisition of Mavens, a leader and pioneer in cloud-based technology solutions for life sciences. The acquisition brings [...]
Associate Editor Roles – IJTAHC
The International Journal of Technology Assessment in Health Care (IJTAHC) is a journal of Cambridge University Press and a key [...]
How a Former Health Care Executive Became a Health Care Whistleblower
Former health care executive Wendell Potter spent part of 2020 publishing high-profile apologies for the work he used to do — the lies [...]
COVID-19 Trial Tracker Updates
In April 2020, Cytel launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, [...]
(Podcast) Bridge the City: Opportunity Costs of Healthcare in the US
Researchers David Vanness and James Lomas joined the Bridge the City podcast to explain the conclusions of their new paper, [...]
[Podcast] How Doctors Can Be a Part of the Solution
In the final episode of our podcast's inaugural season, neurologist Jason Crowell and ICER's President Steve Pearson discuss what physicians [...]
3 Ways That Payers Leveraged Artificial Intelligence in 2020
Payers used artificial intelligence to drive towards key objectives in 2020. Artificial intelligence is not a new technology, with the [...]
Aligning HEOR/RWE Procurement with Finance
Procurement is a business function that offers so much in the way of value. However, its not always easy to [...]
State Level Action in Response to ICER’s Unsupported Price Increase Report
In ICER’s latest report on Unsupported Price Increases (UPI), we determined that 7 of the 10 costliest US drug-price hikes [...]
Janet Woodcock to be Acting FDA Commissioner
Janet Woodcock is set to be the most powerful person at the FDA in less than a week. The veteran [...]
Amgen Tops Cost Watchdog’s Price Gougers List
In a top 10 ranking of the most egregious price gougers from 2019, Amgen’s Enbrel topped US cost watchdog ICER’s [...]
The American Public’s Priorities for the New President and Congress
In a post-election Politico/Harvard poll, an overwhelming 87% of the respondents indicated that “taking federal government action to lower prescription [...]
Webinar: Pathways to ISPOR Leadership
Tune in to the next installment of our leadership development series “Pathways to ISPOR Leadership” with special guest Mike Drummond, [...]
Department of Veterans Affairs Paid About Half as Much as Medicare Part D for Selected Drugs in 2017
A new analysis from the US Government Accountability Office shows that, in 2017, the Department of Veterans Affairs paid prescription drug prices [...]
Fierce JPM Week Partner Content Hub
This is a different approach to enabling our partners to share solutions and stories with you in a virtual environment. [...]
New Book Release by RJG Arnold: Pharmacoeconomics: From Theory to Practice
An understanding of the basic principles of pharmacoeconomics is essential if stakeholders in the healthcare arena hope to meet the [...]
New Data Show Retail Medicine Prices Fell in 2019
In 2019, retail prescription medicine prices declined by 0.4%, on average, according to National Health Expenditures (NHE) data from the Centers for Medicare & [...]
Pandemic Propels Health Systems to Mull Acquisitions, Partnerships
Nearly a year after the first confirmed case of COVID-19 in the U.S., some of the nation's largest health systems [...]
Gaps in Health Data are Barrier to Health Equity
COVID-19 has laid bare racial disparities in the United States health system. For example, COVID-19 cases among Native Hawaiian / [...]
Cerner Aspires to Build $1B Data Business in Pharma Market
Building on its acquisition of clinical research company Kantar Health, health IT giant Cerner is setting its sights on building [...]
[Podcast] Creating an HEOR Function Within Medical Affairs
In this episode of the MAPS Elevate podcast series, we explore Health Economics and Outcomes Research (HEOR), looking at why [...]
Implications of Price Transparency for Providers and Patients as New Rules Go into Effect
A new KFF analysis examines how new federal rules on price transparency for health services may affect patient decision-making and [...]
STaRT-RWE: Structured Template for Planning and Reporting on the Implementation of Real World Evidence Studies
In alignment with the International Council of Harmonization’s strategic goals, a public-private consortium has developed a structured template for planning [...]
Disparities in the Wage‑and‑Salary Earnings of HEOR Professionals
Using self-reported survey data collected in 2017 from a subset of HE/OR/MA professionals in the HealthEconomics.com global subscriber list, researchers [...]